Yes could you pls expand on what do you mean by 'what looks like a failure on the therapy when compared to the currently approved therapy drug' and how today's announcement is any different from what was expected from the previous meetings/presentations? Cheers.
Ann: Q3 2023 Business Update to Accompany Quarterly Results, page-57
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$27.53 |
Change
0.640(2.38%) |
Mkt cap ! $9.214B | |||
| Open | High | Low | Value | Volume |
| $26.92 | $27.53 | $26.56 | $22.05M | 814.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 161 | $27.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $27.60 | 118 | 1 |
View Market Depth
| Last trade - 16.10pm 27/01/2025 (20 minute delay) ? |
| TLX (ASX) Chart |